Massimo Offidani

Massimo Offidani

UNVERIFIED PROFILE

Are you Massimo Offidani?   Register this Author

Register author
Massimo Offidani

Massimo Offidani

Publications by authors named "Massimo Offidani"

Are you Massimo Offidani?   Register this Author

100Publications

3313Reads

45Profile Views

Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.

J Clin Oncol 2018 07 2;36(20):2035-2043. Epub 2018 Feb 2.

Meletios Dimopoulos, National and Kapodistrian University of Athens, Athens, Greece; Katja Weisel, University Hospital of Tuebingen, Tuebingen, Germany; Niels W.C.J. van de Donk, VU Universiteit Medical Center, Amsterdam; Pieter Sonneveld, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Karthik Ramasamy, Oxford University Hospital and NIHR BRC Blood Theme, Oxford; Matthew Streetly, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Barbara Gamberi, Arcispedale S. Maria Nuova, Reggio Emilia; Massimo Offidani, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona; Antonio Ardizzoia, Oncology Department, ASST Lecco, Lecco, Italy; Frank Bridoux, University Hospital and University of Poitiers, Poitiers, France; Javier de la Rubia, Hematology Service University Hospital Doctor Peset and Universidad Católica de Valencia "San Vicente Mártir," Valencia; Maria-Victoria Mateos, Instituto de Investigación Biomédica de Salamanca and University of Salamanca, Salamanca, Spain; Elisabeth Kueenburg, Shona Collins, Antonia Di Micco, Barbara Rosettani, and Pamela Bacon, Celgene International, Boudry, Switzerland; and Yan Li, Translational Development and Clinical Pharmacology, Celgene Corporation, Summit, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.1742DOI Listing
July 2018

Stem Cell Transplantation in Multiple Myeloma.

Curr Cancer Drug Targets 2017 ;17(9):769-781

Division of Hematology, University of Torino, Via Genova 3, 10126 Torino. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009616666160920090236DOI Listing
June 2018

Updated results of a phase 2 study of panobinostat combined with melphalan, thalidomide and prednisone (MPT) in relapsed/refractory multiple myeloma.

Leuk Lymphoma 2018 05 11;59(5):1271-1273. Epub 2017 Sep 11.

e Myeloma Unit, Division of Hematology , University of Torino, Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1372575DOI Listing
May 2018

A review discussing elotuzumab and its use in the second-line plus treatment of multiple myeloma.

Future Oncol 2018 Feb 1;14(4):319-329. Epub 2017 Nov 1.

UOC Medicina, Ospedale Stelluti Scala, Fabriano, Italy.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2017-0371
Publisher Site
http://dx.doi.org/10.2217/fon-2017-0371DOI Listing
February 2018

Triplet vs. doublet drug regimens for managing multiple myeloma.

Expert Opin Pharmacother 2018 02 21;19(2):137-149. Epub 2017 Dec 21.

c UO Ematologia, Department of Medicine , General Hospital Civitanova , Marche , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14656566.2017.1
Publisher Site
http://dx.doi.org/10.1080/14656566.2017.1418856DOI Listing
February 2018

Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma.

Eur J Haematol 2017 Mar 5;98(3):289-295. Epub 2017 Jan 5.

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12834DOI Listing
March 2017

Renal failure in multiple myeloma: something new on the horizon.

Br J Haematol 2017 03 17;176(6):845-846. Epub 2017 Feb 17.

Clinica di Ematologia, AOU Ospedali Riuniti di Ancona, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14548DOI Listing
March 2017

Oral ixazomib maintenance therapy in multiple myeloma.

Expert Rev Anticancer Ther 2016 ;16(1):21-32

a Azienda Ospedaliero-Universitaria , Ospedali Riuniti di Ancona , Ancona , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2016.1123627DOI Listing
September 2016

Ixazomib for the treatment of multiple myeloma.

Expert Opin Investig Drugs 2015 3;24(9):1287-98. Epub 2015 Jul 3.

Dipartimento Oncoematologico, Unità Operativa Complessa di Ematologia, Azienda Ospedaliera di Cosenza , Viale della Repubblica, 87100 Cosenza , Italy +39 0984 681329 ; +39 0984 681866 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2015.1065250DOI Listing
April 2016

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

J Clin Oncol 2015 Sep 3;33(26):2863-9. Epub 2015 Aug 3.

Antonio Palumbo, Stefania Oliva, Simona Caltagirone, Sara Bringhen, and Francesca Gay, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute della Salute e della Scienza di Torino; Roberto Passera, University of Torino, Torino; Massimo Offidani, Clinica di Ematologia, AUO Ospedali Riuniti di Ancona, Ancona; Pellegrino Musto, Istituto di Ricovero e Cura a Carattere Scientifico, Referral Cancer Center of Basilicata, Rionero in Vulture; Maria T. Petrucci, Sapienza University of Rome, Rome; Elena Zamagni and Michele Cavo, Istituto di Ematologia Seragnoli, Università di Bologna, Bologna, Italy; Hervé Avet-Loiseau and Michel Attal, Institut Claudius Regaud, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse; Thierry Facon, Service des Maladies du Sang, Hôpital Claude Huriez, Centre Hospitalier Regionale et Universitaire Lille, Lille; Philippe Moreau, University Hospital Hotel-Dieu, Nantes, France; Henk M. Lokhorst, VU University Medical Center, Amsterdam; Pieter Sonneveld, Erasmus MC, Rotterdam, the Netherlands; Hartmut Goldschmidt, University Hospital and National Center for Tumor Diseases Heidelberg, Heidelberg, Germany; Laura Rosinol, Hospital Clínic, Institut Clínic d'Investigacions Biomèdiques Ausgust Pi i Sunyer, Barcelona; Juan José Lahuerta, Hospital Universitario 12 de Octubre, Madrid; Jésus San Miguel, Clínica Universidad de Navarra, Centro de Investigaciones Médicas Aplicadas, IDISNA, Pamplona, Spain; Paul Richardson and Kenneth C. Anderson, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA; Shaji Kumar and S. Vincent Rajkumar, Mayo Clinic, Rochester, MN; Sagar Lonial, Winship Cancer Institute, Emory University, Atlanta, GA; Robert Z. Orlowski, The University of Texas MD Anderson Comprehensive Cancer Center, Houston, TX; Gareth Morgan, Myeloma Institutes for Research Therapy, University of Arkansas for Medical Sciences, Little Rock, AR; Brian G.M. Durie, Cedars-Sinai Comprehensive Canc

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/03/JCO.2015.61
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.2267
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.2267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846284PMC
September 2015

Smoldering multiple myeloma: to treat or not to treat.

Expert Opin Pharmacother 2015 Apr 8;16(6):785-90. Epub 2015 Feb 8.

Unità Operativa di Ematologia Azienda Ospedaliera di Cosenza , Cosenza , Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1007952DOI Listing
April 2015

Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data.

Leuk Lymphoma 2015 Mar 27;56(3):559-67. Epub 2014 Jun 27.

Department of Hematology, University of Turin , Turin , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.915545DOI Listing
March 2015

Autologous transplantation and maintenance therapy in multiple myeloma.

N Engl J Med 2014 Sep;371(10):895-905

From the Myeloma Unit, Division of Hematology, University of Turin (A.P., F.C., F.G., C. Cerrato, M.G., P.O., M.B.), and Unit of Clinical Epidemiology and Centro di Referimento per l'Epidemiologia-Piemonte, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino (A.E., G.C.), Turin, Division of Hematology, Ospedale Ferrarotto, Azienda Policlinico-Ospedale Vittorio Emanuele, University of Catania, Catania (F.D.R.), Hematology, Sapienza University of Rome (M.T.P.), and Cattedra di Ematologia, Ospedale S. Eugenio-University Tor Vergata (T.C.), Rome, Divisione di Ematologia, Ospedale S. Gerardo, Monza (S.P.), La Struttura Complessa di Ematologia, Dipartimento di Ematologia ed Oncologia, Azienda Ospedaliera Niguarda Ca' Granda (A.C.), Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute (M.M.), and Division of Hematology and Bone Marrow Transplantation, IRCCS Istituto Nazionale dei Tumori-University of Milan (P.C.), Milan, Ematologia, Policlinico Federico II, Naples (L.C.), Clinica di Ematologia, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona (M.O.), Unità Operativa Complessa Ematologia 1, IRCCS Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genoa (A.M.C.), Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna (E.Z., M.C.), Clinica Ematologia, Dipartimento di Scienze Mediche Sperimentali e Cliniche, Azienda Ospedaliera-Universitaria di Udine, Udine (F.P.), Scientific Direction, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (P.M.), and Struttura Complessa Ematologia e Dipartimento Oncologia Medica, Spedali Civili di Brescia, Brescia (C. Crippa) - all in Italy; and the Hematology Division, Hadassah University Hospital, Jerusalem (D.B.Y.), and the Hematology Institute, Chaim Sheba Medical Center, Tel Hashomer (E.R., A.N.) - both in Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1402888DOI Listing
September 2014

Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia.

J Clin Oncol 2014 May 14;32(14):1463-71. Epub 2014 Apr 14.

Giampaolo Bucaneve, Stelvio Ballanti, and Albano Del Favero, Ospedale S. Maria della Misericordia, Perugia, Italy; Alessandra Micozzi, Giuseppe Gentile, and Robin Foà, "Sapienza" Università di Roma, Roma; Marco Picardi, A. O. Universitaria "Federico II," Napoli; Nicola Cascavilla, Ospedale Casa Sollievo della Sofferenza, IRCCS, San Giovanni Rotondo; Prassede Salutari, Ospedale Civile "Spirito Santo," Pescara; Giorgina Specchia, Università di Bari, Bari; Rosa Fanci, A. O. Universitaria "Careggi," Firenze; Mario Luppi, A. O. Universitaria Policlinico, Modena; Laura Cudillo, Policlinico Tor Vergata, Roma; Renato Cantaffa, A. O. "Pugliese Ciaccio," Catanzaro; Giuseppe Milone, Policlinico "Vittorio Emanuele," Catania; Monica Bocchia, Policlinico "S. Maria alle Scotte," Siena; Giovanni Martinelli, Istituto Europeo Oncologico, Milano; Massimo Offidani, A. O. Universitaria-Ospedali Riuniti, Ancona; Anna Chierichini, Ospedale S. Giovanni Addolorata, Roma; Francesco Fabbiano, Ospedali Riuniti, Palermo; Giovanni Quarta, Ospedale "A. Perrino," Brindisi; Valeria Primon, Ospedale SS Antonio e Biagio, Alessandria; Bruno Martino, A. O. "Bianchi-Melacrino-Morelli," Reggio Calabria; Annunziata Manna, ASL5, La Spezia; Eliana Zuffa, Ospedale S. Maria delle Croci, Ravenna; and Antonella Ferrari, A. O. Sant'Andrea, Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.6963DOI Listing
May 2014

Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data.

Expert Rev Anticancer Ther 2014 May 17;14(5):499-510. Epub 2014 Apr 17.

Clinica di Ematologia, AOU Ospedali Riuniti di Ancona, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.906904DOI Listing
May 2014

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.

J Clin Oncol 2014 Mar 21;32(7):634-40. Epub 2014 Jan 21.

Antonio Palumbo, Sara Bringhen, Alessandra Larocca, Valeria Magarotto, Paola Omedé, Roberto Mina, Mario Boccadoro, and Giulia Benevolo, Azienda Ospedaliera (A.O.) Città della Salute e della Scienza di Torino; Daniela Gottardi, A.O. Ordine Mauriziano; Roberto Passera, San Giovanni Battista Hospital, University of Torino, Torino; Davide Rossi and Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara; Francesco Di Raimondo, Ferrarotto Hospital, University of Catania, Catania; Francesca Patriarca, A.O. Universitaria, Udine; Anna Levi and Maria Teresa Petrucci, Sapienza University of Rome; Luca Franceschini, Tor Vergata University Hospital, Rome; Iolanda Donatella Vincelli, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria; Mariella Grasso, S. Croce e Carle Hospital, Cuneo; Renato Zambello, Università degli Studi di Padova, Padova; Vittorio Montefusco, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori Milano, University of Milano, Milan; Antonietta Pia Falcone, IRCCS Casa Sollievo della Sofferenza and Unità di Ematologia, San Giovanni Rotondo; Roberto Marasca, University of Modena, Modena; Fortunato Morabito, A.O. di Cosenza, Cosenza; Tommasina Guglielmelli, "S. Luigi Gonzaga" Hospital, Orbassano; Chiara Nozzoli, A.O. Universitaria Careggi, Firenze; Massimo Offidani, Ospedali Riuniti, Ancona; Roberto Ria, University of Bari "Aldo Moro" Medical School, Bari; Pellegrino Musto, IRCCS-Centro Regionale Oncologico Basilicata, Rionero in Vulture; and Michele Cavo, Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.0023DOI Listing
March 2014

Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.

Expert Opin Biol Ther 2012 Nov 13;12(11):1449-62. Epub 2012 Jul 13.

Divisione di Ematologia con Trapianto di Midollo Osseo e Terapia Intensiva, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14712598.2012.70
Publisher Site
http://dx.doi.org/10.1517/14712598.2012.707185DOI Listing
November 2012

How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinions.

Expert Opin Investig Drugs 2011 Jun 7;20(6):779-93. Epub 2011 Apr 7.

Clinica di Ematologia, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.575060DOI Listing
June 2011

Thalidomide for treatment of multiple myeloma: 10 years later.

Blood 2008 Apr 1;111(8):3968-77. Epub 2008 Feb 1.

Division of Hematology, University of Torino, Azienda Ospedaliera S Giovanni Battista, Torino, Italy.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2007-10-11
Publisher Site
http://dx.doi.org/10.1182/blood-2007-10-117457DOI Listing
April 2008

Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma.

Eur J Haematol 2007 Apr 5;78(4):297-302. Epub 2007 Feb 5.

Clinica di Ematologia Polo Ospedaliero-Universitario, Ospedali Riuniti Ancona Università Politecnica delle Marche, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2007.00823.xDOI Listing
April 2007

Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignancies.

Support Care Cancer 2006 Aug 15;14(8):874-7. Epub 2006 Feb 15.

Clinica di Ematologia, Ospedali Riuniti, Università Politecnica delle Marche, Ancona, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-006-0030-0DOI Listing
August 2006

Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL).

Leuk Lymphoma 2005 Feb;46(2):233-8

Clinica di Ematologia, Università Politechnica delle Marche, Azienda Ospedaliera Umberto I, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190400019917DOI Listing
February 2005

Mucormycosis in hematologic patients.

Haematologica 2004 Feb;89(2):207-14

Dipartimento de Medicina Clinica-Azienda Ospedaliera Universitaria Federico II, Napoli, Italy.

View Article

Download full-text PDF

Source
February 2004